IDYA
IDEAYA BiosciencesCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
9
U.S. public peers
Grade Position
In line
vs peer average
IDYA vs peer average
57/100
IDYA vs. peer average (C vs. C)
Grade spread
A 1 · B 2 · C 1 · D 2 · F 3
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
RCUS is the first available peer comparator.
Closest listed oncology-oriented peer in the packet, but modality, pipeline maturity, and clinical assets differ materially; useful mainly for SMID-cap oncology sentiment context.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IDYA
IDEAYA Biosciences
RCUS
Arcus Biosciences
Grade
C
B
Momentum
68
44
Value
41
41
Sentiment
57
72
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs RCUS
IDYA / RCUS
Grade Position
In line
IDYA vs. peer average (C vs. C)
57/100
Momentum
68
IDYAValue
41
IDYASentiment
57
RCUSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IDYA
RCUS is the first peer returned for this comparison set.